<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microb Cell Fact</journal-id><journal-id journal-id-type="iso-abbrev">Microb Cell Fact</journal-id><journal-title-group><journal-title>Microbial Cell Factories</journal-title></journal-title-group><issn pub-type="epub">1475-2859</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">10983751</article-id><article-id pub-id-type="publisher-id">2363</article-id><article-id pub-id-type="doi">10.1186/s12934-024-02363-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Genetic toolbox for <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic>: pSEVA based heterologous expression systems and CRISPR/Cpf1 based genome editing for rapid natural product profiling</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5291-7759</contrib-id><name><surname>Rill</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6048-5909</contrib-id><name><surname>Bode</surname><given-names>Helge B.</given-names></name><address><email>helge.bode@mpi-marburg.mpg.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05r7n9c40</institution-id><institution-id institution-id-type="GRID">grid.419554.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0491 8361</institution-id><institution>Department of Natural Products in Organismic Interactions, </institution><institution>Max-Planck Institute for Terrestrial Microbiology, </institution></institution-wrap>35043 Marburg, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04cvxnb49</institution-id><institution-id institution-id-type="GRID">grid.7839.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9721</institution-id><institution>Molecular Biotechnology, Department of Biosciences, </institution><institution>Goethe University Frankfurt, </institution></institution-wrap>60438 Frankfurt am Main, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rdrb571</institution-id><institution-id institution-id-type="GRID">grid.10253.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9756</institution-id><institution>Department of Chemistry, Chemical Biology, </institution><institution>Phillips University Marburg, </institution></institution-wrap>35043 Marburg, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rdrb571</institution-id><institution-id institution-id-type="GRID">grid.10253.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9756</institution-id><institution>Center for Synthetic Microbiology (SYNMIKRO), </institution><institution>Phillips University Marburg, </institution></institution-wrap>35043 Marburg, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00xmqmx64</institution-id><institution-id institution-id-type="GRID">grid.438154.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0944 0975</institution-id><institution>Senckenberg Gesellschaft f&#x000fc;r Naturforschung, </institution></institution-wrap>60325 Frankfurt, Germany </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>State Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Shanghai, 200032 China </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>23</volume><elocation-id>98</elocation-id><history><date date-type="received"><day>17</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>11</day><month>3</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Bacteria of the genus <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic> are motile, Gram-negative bacteria that live in symbiosis with entomopathogenic nematodes. Due to their complex life cycle, they produce a large number of specialized metabolites (natural products) encoded in biosynthetic gene clusters (BGC). Genetic tools for <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic> have been rare and applicable to only a few strains. In the past, several tools have been developed for the activation of BGCs and the deletion of individual genes. However, these often have limited efficiency or are time consuming. Among the limitations, it is essential to have versatile expression systems and genome editing tools that could facilitate the practical work.</p></sec><sec><title>Results</title><p id="Par2">In the present study, we developed several expression vectors and a CRISPR-Cpf1 genome editing vector for genetic manipulations in <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic> using SEVA plasmids. The SEVA collection is based on modular vectors that allow exchangeability of different elements (e.g. origin of replication and antibiotic selection markers with the ability to insert desired sequences for different end applications). Initially, we tested different SEVA vectors containing the broad host range origins and three different resistance genes for kanamycin, gentamycin and chloramphenicol, respectively. We demonstrated that these vectors are replicative not only in well-known representatives, e.g. <italic>Photorhabdus laumondii</italic> TTO1, but also in other rarely described strains like <italic>Xenorhabdus</italic> sp. TS4. For our CRISPR/Cpf1-based system, we used the pSEVA231 backbone to delete not only small genes but also large parts of BGCs. Furthermore, we were able to activate and refactor BGCs to obtain high production titers of high value compounds such as safracin B, a semisynthetic precursor for the anti-cancer drug ET-743.</p></sec><sec><title>Conclusions</title><p id="Par3">The results of this study provide new inducible expression vectors and a CRISPR/CPf1 encoding vector all based on the SEVA (Standard European Vector Architecture) collection, which can improve genetic manipulation and genome editing processes in <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic>.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12934-024-02363-8.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>CRISPR/Cpf1</kwd><kwd><italic>Xenorhabdus</italic></kwd><kwd><italic>Photorhabdus</italic></kwd><kwd>Genome editing</kwd><kwd>Safracin</kwd><kwd>Natural products</kwd></kwd-group><funding-group><award-group><funding-source><institution>Max Planck Institute for Terrestrial Microbiology (2)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par4">Microorganisms often use low-molecular weight compounds to interact with other organisms in complex environments [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. These compounds, also known as secondary or specialized metabolites or natural products can be structurally and functionally diverse [<xref ref-type="bibr" rid="CR4">4</xref>]. Their ecological function ranges from defense against competitors or enemies [<xref ref-type="bibr" rid="CR5">5</xref>], cell-cell communication, to symbiosis and pathogenesis [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. These functions also allow their application in medicine, for example, as anticancer or antibacterial drugs [<xref ref-type="bibr" rid="CR8">8</xref>]. Increasing numbers of infectious diseases caused by bacteria and viruses make it necessary to constantly find new natural products serving as drug candidates also against antimicrobial resistant pathogens. Since climate change as well as other human impact on our planet also plays an important role in the occurrence of such infectious diseases, the demand for such compounds likely will even increase in the future [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par5">The progress in sequencing technology opens up new possibilities to study the genomic and metabolic diversity of microorganisms [<xref ref-type="bibr" rid="CR11">11</xref>]. In addition, there are numerous tools and databases for the prediction of genes related to the biosynthesis of secondary metabolites that enable simple and accurate genome mining [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In general, the predicted number of biosynthetic gene clusters (BGCs) responsible for the production of natural products in any genome outcompetes the number of produced natural product types observed under laboratory conditions [<xref ref-type="bibr" rid="CR14">14</xref>]. Therefore, robust and versatile molecular tools need to be developed to activate BGCs that might be silent under laboratory conditions. One possibility is to express the BGC heterologous in related organisms [<xref ref-type="bibr" rid="CR15">15</xref>]. For this purpose, several methods have been established to assemble large DNA fragments, such as TAR cloning (Transformation-Associated Recombination) and ExoCET, which is based on the Red/ET recombineering tool [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>]. Another way to activate BGCs is to manipulate the regulatory network in the native host. Since promoters are the first target for regulatory mechanisms, methods have been developed to increase their strength, replace them with a set of regulatory sequences with known functions resulting in the exchange of the natural against an inducible promoter [<xref ref-type="bibr" rid="CR20">20</xref>] or to prevent binding of repressors to the promoter sequence [<xref ref-type="bibr" rid="CR21">21</xref>]. Various methods have been developed for this purpose, such as a phage recombinase-based knock-in approach, in which an antibiotic resistance gene including promoter was integrated in front of a gene cluster [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The increasingly common method of CRISPR/Cas also offers a good opportunity for seamless and precise chromosomal integration or replacement of heterologous sequences for BGC activation [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par6">Bacteria of the genus <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic> are a prolific source for several natural products [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Due to their particular life cycle that involved interaction with a nematode host, insect prey and other microbes and organisms as competitors, they produce natural products showing activity in cell-cell communication or antibiotic, antifungal, insecticidal and cytotoxic activity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par7">Molecular tools have also been developed for <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic> to elucidate new natural products and genes involved. The easy Promoter Activated Compound Identification (easyPACId) method is based on the integration of a non-replicating plasmid containing an R6K ori with a heterologous promoter in front of a BGC. Coupled with the deletion of the gene encoding the global regulator Hfq, the production of individual compound classes from one BGC in an almost clear metabolic background can be achieved [<xref ref-type="bibr" rid="CR32">32</xref>]. A CRISPR/Cas9 system was also established recently for <italic>Photorhabdus laumondii</italic> TTO1. Based on Cre-lox recombinase-mediated genome engineering and stepwise integration of the Cas9 gene and sgRNA into the chromosome of the target organism, subsequent integration of individual sgRNAs and repair donor templates allows for sequential deletion of genes of interest [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par8">In addition to the well-established type II CRISPR/Cas9 system, the use of a type V-A CRISPR-Cas system (CRISPR-Cpf1) is becoming increasingly widespread. Unlike Cas9, only a single crRNA is required and the <italic>cas12</italic> gene is smaller than <italic>cas9</italic>, while it recognizes a 4-base pair, T-rich protospacer adjacent motif (PAM) [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par9">Here we report the development of pSEVA based expression systems with a variety of replication origins, resistant genes and promoters. Furthermore, we developed an efficient and simple genome editing strategy using a CRISPR/Cpf1 system assisted by &#x003bb; red system recombination encoded on a single &#x0201c;all-in-one&#x0201d; plasmid (pAR20) in <italic>Photorhabdus laumondii</italic> TTO1, <italic>Xenorhabdus nematophila</italic> and <italic>Xenorhabdus</italic> sp. TS4. Besides deletions and promoter exchanges, we apply our approach to the activation and optimization of the previously described and characterized safracin B (SAC-B, <bold>16</bold>) in <italic>Xenorhabdus sp</italic>. TS4 up to a final production titer of 336&#x000a0;mg/L. Safracins have been previously described and characterized in <italic>Pseudomonas fluorescens</italic> [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. They belongs to the tetrahydroisoquinoline (THIQ) family natural products with unusual scaffolds and bioactivities [<xref ref-type="bibr" rid="CR38">38</xref>]. The most prominent of the THIQ family, ET-743, has already been approved by the Food and Drug Administration for the treatment of soft tissue sarcomas [<xref ref-type="bibr" rid="CR39">39</xref>]. However, ET-743 is difficult to obtain directly from its natural source [<xref ref-type="bibr" rid="CR40">40</xref>]. Therefore, extensive synthesis studies have been performed [<xref ref-type="bibr" rid="CR41">41</xref>] although the main industrial production is by semi-synthesis using cyanated safracin B as starting material [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>].</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Strains, plasmids, and growth conditions</title><p id="Par10">All bacterial strains and plasmids used in this study are listed in Table <xref rid="MOESM2" ref-type="media">S1</xref>. <italic>E</italic>. <italic>coli</italic> DH10B were used as host for plasmid construction, <italic>E</italic>. <italic>coli</italic> ST18 was used as donor strain for conjugation to transfer plasmids into <italic>Photorhabdus laumondii</italic> TTO1 and <italic>Xenorhabdus nematophila</italic> ATCC 19061. <italic>E. coli</italic> was cultured in LB medium at 37&#x000a0;&#x000b0;C, and <italic>Photorhabdus/Xenorhabdus</italic> was cultured in LB medium at 30&#x000a0;&#x000b0;C. All liquid cultures were incubated at 200&#x000a0;rpm and antibiotics were added as follows: 50&#x000a0;&#x000b5;g/ml kanamycin (Km), 50&#x000a0;&#x000b5;g/ml chloramphenicol (Cm) and/or 50&#x000a0;&#x000b5;g/ml gentamycin (Gm) for <italic>E. coli</italic>. 25&#x000a0;&#x000b5;g/ml kanamycin, 15&#x000a0;&#x000b5;g/ml chloramphenicol and 7.5&#x000a0;&#x000b5;g/ml gentamycin were used for <italic>Photorhabdus/Xenorhabdus</italic>. 15&#x000a0;g/L agar was added to LB for agar plates. In addition, the concentration of L-arabinose (Ara) and anhydrotetracycline (ATC) to induce expression of the Cpf1 protein and lambda red proteins was 0.4% (w/v) and 200 nM, respectively. For inducing of genome-integrated promoters, 100 &#x000b5;M of vanillic acid (VA) and 1 mM IPTG was used. Plasmid based expression was induced with 0.2% (w/v) L-arabinose, 100 &#x000b5;M vanillic acid, 1mM IPTG and 100 &#x000b5;M coumaric acid, respectively. All strains were kept as glycerol stocks prepared in LB containing 25% glycerol at &#x02212;&#x02009;80&#x000a0;&#x000b0;C.</p></sec><sec id="Sec4"><title>Construction of editing plasmids</title><p id="Par111">All plasmids used in the study are listed in Table&#x000a0;<xref rid="MOESM2" ref-type="media">1</xref> in Additional File 2. Sequences of the crRNAs, primers and synthetic DNA fragments used in the study are in listed in Additional File 2. pAR16 harboring <italic>cpf1</italic> and lambda red genes harboring vector was constructed by exchanging of the origin of replication via NEB Hifi assembly. AR426/427 was used for backbone amplification from p46Cpf1-OP2 (obtained from Addgene) and AR428/429 was used to amplify the p15A ori from a pACYC-derived vector. pAR18 was constructed in three steps: (1) pTargetF (obtained from Addgene) was linearized with the primer pair AR430/431 while the <italic>cas9</italic> sgRNA sequence was replaced by the <italic>sacB</italic> gene including its native promoter (amplified with AR432/433 from pEP17-KM [<xref ref-type="bibr" rid="CR44">44</xref>]); the final pAR14 was assembled via NEB Hifi assembly. (2) To exchange the spectinomycin resistance, pAR14 was linearized by restriction digestion with <italic>Xho</italic>I and <italic>Sac</italic>I; the desired fragment was purified via gel extraction (Monarch&#x000ae; DNA Gel Extraction Kit) and assembled with the gentamycin resistance gene amplified from pSEVA631 (AR434/435) to obtain pAR15; (3) In the last step, the Cpf1 crRNA framework encoded on a synthetic gene fragment (synthesized by GENEWIZ Germany GmbH) was inserted into the linearized pAR15 (AR436/437) via NEB Hifi assembly, giving pAR18.</p><p id="Par11">All plasmids used in the study are listed in Table&#x000a0;<xref rid="MOESM2" ref-type="media">1</xref> in Additional File 2. Sequences of the crRNAs, primers and synthetic DNA fragments used in the study are in listed in Additional File 2. pAR16 harboring <italic>cpf1</italic> and lambda red genes harboring vector was constructed by exchanging of the origin of replication via NEB Hifi assembly. AR426/427 was used for backbone amplification from p46Cpf1-OP2 (obtained from Addgene) and AR428/429 was used to amplify the p15A ori from a pACYC-derived vector. pAR18 was constructed in three steps: (1) pTargetF (obtained from Addgene) was linearized with the primer pair AR430/431 while the <italic>cas9</italic> sgRNA sequence was replaced by the <italic>sacB</italic> gene including its native promoter (amplified with AR432/433 from pEP17-KM [<xref ref-type="bibr" rid="CR44">44</xref>]); the final pAR14 was assembled via NEB Hifi assembly. (2) To exchange the spectinomycin resistance, pAR14 was linearized by restriction digestion with <italic>Xho</italic>I and <italic>Sac</italic>I; the desired fragment was purified via gel extraction (Monarch&#x000ae; DNA Gel Extraction Kit) and assembled with the gentamycin resistance gene amplified from pSEVA631 (AR434/435) to obtain pAR15; (3) In the last step, the Cpf1 crRNA framework encoded on a synthetic gene fragment (synthesized by GENEWIZ Germany GmbH) was inserted into the linearized pAR15 (AR436/437) via NEB Hifi assembly, giving pAR18.</p><p id="Par12">The empty pAR20 was constructed <italic>in silico</italic> and synthesized as whole plasmid by Double Helix Technologies (DOULIX&#x02122;). pAR20 editing plasmids were assembled via NEB Golden Gate Assembly. Target sequence and homology repair templates, ordered as synthetic dsDNA gene fragments, and were obtained from Twist Bioscience and Integrated DNA Technologies, respectively. The NEB Golden Gate Assembly mix containing pAR20 and dsDNA inserts was prepared according to the manufacturer&#x02019;s instructions. Correct assembly was checked by colony PCR using primer pair AR533/534.</p></sec><sec id="Sec5"><title>Electrotransformation and biparental conjugation</title><p id="Par13">Electrocompetent <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic> cells were prepared as previously described [<xref ref-type="bibr" rid="CR17">17</xref>]. For conjugation of the pAR20/pSEVA derivatives overnight cultures of <italic>E</italic>. <italic>coli</italic> ST18 and <italic>Photorhabdus</italic>/<italic>Xenorhabdus</italic> were used, respectively. The optical density of the two cultures was measured and set to a ratio of 4:1 Recipient/Donor in a total volume of 1&#x000a0;ml. The cell mixture was centrifuged at 5000 x g and washed twice with 1&#x000a0;ml LB. Finally, the cell pellet was resuspended in 100&#x000a0;&#x000b5;l LB and spotted onto a LB agar plate containing 50&#x000a0;&#x000b5;g/ml aminolevulinic acid. The next day, the cell mass was scraped off and resuspended in 1&#x000a0;ml LB. A dilution of 1:50 was plated on a selection plate with appropriate antibiotics.</p></sec><sec id="Sec6"><title>Cpf1 assisted gene editing with pAR20 series and plasmid curing</title><p id="Par14">For general gene editing, a strain carrying a gene-specific pAR20 vector was inoculated as a 5&#x000a0;ml overnight culture in a 50&#x000a0;ml Erlenmeyer flask. The next day, this culture was diluted to a final OD of 0.5 in 10&#x000a0;ml LB containing 25&#x000a0;&#x000b5;g/ml kanamycin. The culture was then incubated at 30&#x000a0;&#x000b0;C until an OD of 0.8&#x02013;1.0 was reached. After addition of ATC, the culture was further incubated at 25&#x000a0;&#x000b0;C for 1&#x000a0;h.</p><p id="Par15">Subsequently, L-arabinose was added and incubated for another 3&#x000a0;h at the same temperature. Finally, 50&#x000a0;&#x000b5;l of the cell suspension was plated on a selection plate with kanamycin and arabinose. Successful editing approaches were confirmed by colony PCR [<xref ref-type="bibr" rid="CR45">45</xref>].</p><p id="Par16">For plasmid curing, the overnight culture of the plasmid containing strain was diluted 1:500 into fresh LB medium containing 10% sucrose and incubated for further 20&#x000a0;h. This culture could be used directly for further rounds of genome editing or was plated on solid medium with or without sucrose (10%). Additionally, we checked for the presence of kanamycin resistance gene with colony PCR and the primer pair km_fw/rev.</p></sec><sec id="Sec7"><title>Construction of expression plasmids</title><p id="Par17">To generate pSEVA-based expression vectors, the empty pSEVA plasmids were amplified with the primer pair AR1081/AR900. The resulting PCR fragments were assembled with NEBuilder&#x000ae; HiFi DNA Assembly Master Mix together with mNeonGreen synthetic dsDNA fragment and synthetic dsDNA fragments of the selected promoters. For further use as an expression vector template, the cloned plasmids were amplified with the primer pair AR900/970 and assembled with the desired insert fragment.</p></sec><sec id="Sec8"><title>Construction of plasmids for expression of safracin derivatives</title><p id="Par18">For construction of the expression plasmids in <italic>E. coli mtaA</italic> (<italic>E</italic>. <italic>coli</italic> DH10b strain with genome integrated phosphopantetheinyl transferases MtaA, essential for activation of NRPS) pCOLA, pACYC and pCDF empty backbones were linearized by restriction digest with <italic>NcoI</italic> and <italic>PstI</italic>. Inserts were amplified by PCR with the according primer pairs (Additional File Table&#x000a0;<xref rid="MOESM2" ref-type="media">1</xref>) and purified via gel extraction (Monarch&#x000ae; DNA Gel Extraction Kit). Purified PCR fragments were assembled with the corresponding plasmid backbones by HiFi cloning (NEB; E2621L). Subsequently the assembly mix was transformed by electro transformation into <italic>E. coli mtaA</italic>. Positive clones were verified by restriction digest.</p><sec id="Sec9"><title>Safracin A and B production</title><p id="Par19">For the production of safracin A and B a single colony of the selected strain was inoculated in 5&#x000a0;ml LB with appropriate antibiotics for overnight cultivation. After 18&#x000a0;h, the overnight culture was diluted 1:50 in 45&#x000a0;ml fresh LB medium with antibiotics and incubated at 30&#x000a0;&#x000b0;C until OD 0.8 was reached. Subsequently the culture was centrifuged in a 50&#x000a0;ml centrifugation tube at 20&#x000a0;&#x000b0;C and 3725 x g. The supernatant was discarded and the cell pellet was resuspended in 15&#x000a0;ml fresh modified Bacto&#x02122; CD Supreme Fermentation Production Medium (supplemented with 1 mM L-tyrosine, 1 mM L-methionine, 0.5&#x000a0;g/L L-leucine, 1&#x000a0;g/L pyruvate, 1&#x000a0;ml/L trace element solution as described in [<xref ref-type="bibr" rid="CR32">32</xref>], 2&#x000a0;ml/L vitamine solution as described in [<xref ref-type="bibr" rid="CR32">32</xref>] and 1% (w/v) sodium succinate as carbon source). Inducers for BGC activation and Amberlite&#x02122; XAD16N resin (2% final) were added after 1&#x000a0;h cultivation at 28&#x000a0;&#x000b0;C. The Amberlite&#x02122; XAD16N resin was harvested after 3&#x000a0;day of cultivation and extracted with a culture volume equivalent of methanol. Methanol extracts were centrifuged at 13,000&#x000a0;rpm for 30&#x000a0;min and transferred to HPLC vials at a final dilution of 1:100. All mass spectrometry measurements were performed using an Ultimate 3000 LC system (Dionex; gradient MeCN/0.1% formic acid in H<sub>2</sub>O/0.1% formic acid, 5&#x02013;95%, 15&#x000a0;min, flow rate 0.4 mL/min, ACQUITY UPLC BEH C18 column 1.7&#x000a0;&#x003bc;m 2.1&#x000a0;mm&#x000d7;100&#x000a0;mm (Waters)) coupled to an AmaZonX (Bruker) electron spray ionization (ESI) mass spectrometer in positive ionization mode or an Impact II qTof (Bruker) with internal 10 mM sodium formate calibrator for high resolution data&#x000a0;[<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Data Analysis 4.3 software (Bruker) was used to evaluate the measurements. SAC-B concentrations were quantified by serial dilution and resulting standard curve of a standard of SAC-B obtained from Focus Biomolecules (CAS: 87578-99-2, Catalog Number: 10-3208). SAC-A was also quantified using this standard curve.</p></sec><sec id="Sec10"><title>Production and isolation of safracin derivative 20</title><p id="Par20">The compound <bold>20</bold> was isolated from heterologous expression of the safracin homologous gene cluster containing the genes xets_03193&#x02013;03202 without the peptidase-encoding gene xets_03192 from <italic>Xenorhabdus</italic> TS4 in <italic>E. coli mtaA</italic>. The production of compound <bold>20</bold> by the heterologous <italic>E. coli</italic> was confirmed by HPLC-MS analysis. To isolate compound <bold>20</bold>, overnight cultures of the heterologous <italic>E. coli</italic> were inoculated into LB medium with appropriate antibiotics and 0.1% L-arabinose (from a 25% stock solution) added. The cultures were cultivated at 30&#x000a0;&#x000b0;C and 200&#x000a0;rpm on a rotary shaker. The cells were harvested after 3 days and extracted with MeOH by ultrasonic method for 15&#x000a0;min. The extract was purified by semipreparative HPLC system using a gradient MeCN/H<sub>2</sub>O solution containing 0.1% formic acid to yield the compound <bold>20</bold>. The structure of the compound <bold>20</bold> was confirmed by HR-MS m/z 763.4994 [M&#x02009;+&#x02009;H]<sup>+</sup> (calc. for C<sub>44</sub>H<sub>67</sub>N<sub>4</sub>O<sub>7</sub>, 763.5004; &#x00394;ppm 1.35) and NMR (Table <xref rid="MOESM2" ref-type="media">S4</xref> and Figures <xref rid="MOESM2" ref-type="media">S8-12</xref>). NMR spectra for purified compounds were measured in DMSO-<italic>d</italic><sub><italic>6</italic></sub>.</p></sec></sec><sec id="Sec11"><title>Isolation and analysis of other natural products</title><p id="Par21">For production of all other natural products, <italic>Photorhabdus/Xenorhabdus</italic> strains were cultured in XPP medium [<xref ref-type="bibr" rid="CR32">32</xref>] at 28&#x000a0;&#x000b0;C and 200&#x000a0;rpm for 3 days. Subsequently the culture was extensively mixed 1:1 with methanol for 5&#x000a0;min. All mass spectrometry measurements were performed as described above.</p></sec></sec><sec id="Sec12"><title>Results and discussion</title><sec id="Sec212"><title>Construction of conjugatable expression vectors for <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic></title><p id="Par23">To create a conjugatable library of expression vectors for <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic>, we used pSEVA plasmids obtained from seva-plasmids.com as a template. Their architecture allows to quickly adapting the origin of replication and resistance gene to the desired strain. We linearized the vectors and assembled them with modified promoters (<italic>vanR</italic>/P<sub>vanCC</sub>, l<italic>acI</italic>/P<sub>tac</sub>, <italic>cymR</italic>/P<sub>cymRC</sub> and <italic>araC</italic>/P<sub>Bad</sub>) as described previously [<xref ref-type="bibr" rid="CR48">48</xref>]. To test their functionality, we additionally assembled the gene encoding the fluorescence protein mNeonGreen on our expression vectors [<xref ref-type="bibr" rid="CR49">49</xref>]. The vectors were introduced into the target strains by conjugation and tested for expression of mNeonGreen by addition of the inducers directly into the LB-Agar. We therefore were able to generate a library of 26 vectors with the resistance genes for gentamycin, kanamycin and chloramphenicol as well as the replication origins pBBR1, p15A, pUC, RK2, RSF1010 and pRO1600/ColE1 (Table <xref rid="MOESM2" ref-type="media">S1</xref>, Plasmids).</p></sec><sec id="Sec112"><title>Optimization of the two-plasmid-based CRISPR/Cpf1 method for <italic>Photorhabdus</italic></title><p id="Par25">The CRISPR/Cpf1 editing method described here is based on the method previously described for <italic>E</italic>. <italic>coli</italic> [<xref ref-type="bibr" rid="CR50">50</xref>]. It consists of a helper and a donor plasmid, which are used to perform genome editing supported by the lambda recombination system. The helper plasmid p46Cpf1-OP2 encodes an <italic>E. coli</italic> codon-optimized variant of the cpf1 gene under the PBad promoter (inducible with L-arabinose (Ara)) and the lambda red (<italic>gam</italic>, <italic>exo</italic>, <italic>bet</italic>) recombination system controlled by a Ptet promoter (inducible with anhydrotetracycline (ATC)). The donor plasmid is based on a high copy pUC vector carrying the crRNA sequence for a specific target gene, as well as homology regions to the target sequence that serve as repair templates after double-strand breaks.</p><p id="Par26">In order to validate this method in <italic>Photorhabdus laumondii</italic> TTO1, the <italic>stlA</italic> gene (<italic>plu2234</italic>) was selected as the first target for genome editing because of an easily recognizable phenotype (Fig. <xref rid="MOESM2" ref-type="media">S1</xref> A). StlA is a phenylalanine ammonia lyase involved in the biosynthesis of isopropylstilbene (IPS; <bold>1</bold>) produced by all <italic>Photorhabdus</italic> strains (Fig. <xref rid="MOESM2" ref-type="media">S1</xref> A) and its deletion results in overproduction of the orange anthraquinone pigments [<xref ref-type="bibr" rid="CR51">51</xref>].</p><p id="Par27">We constructed a new donor plasmid (pAR18, Fig. <xref rid="MOESM2" ref-type="media">S1</xref> B) based on the pTargetF vector with gentamycin resistance as well as the <italic>sacB</italic> gene as counter-selection marker enabling rapid loss of the donor plasmid allowing for several rounds of genome editing. Unlike the original method, we decided to use two spacer sequences for each deletion to enable targeting of the leading and lagging strand, respectively. For this purpose, we constructed a synthetic framework consisting of the constitutive promoter J23119, a transcriptional terminator and the direct repeats of the crRNA sequence. We modified the described CRISPR array [<xref ref-type="bibr" rid="CR35">35</xref>] and replaced the spacer sequence between the FnCpf1 specific direct repeats by two <italic>Bsa</italic>I restriction sites containing sequence (Fig. <xref rid="MOESM2" ref-type="media">S1</xref>B). The <italic>stlA</italic> specific spacer sequences were determined by &#x0201c;Annotate &#x00026; Predict&#x0201d; function of Geneious Prime, &#x0201c;TTTN&#x0201d; was set as PAM site and a spacer sequence length of 31&#x000a0;bp. Furthermore, to facilitate plasmid assembly, the homology repair arms (HR-L/HR-R; &#x0223c;500&#x000a0;bp) were each coupled with one of the crRNAs and synthesized as a dsDNA fragment (Fig. <xref rid="MOESM2" ref-type="media">S1</xref> B; dsDNA/ dsDNA-R). The resulting <italic>stlA</italic>-specific pAR18, assembled by the Golden Gate reaction, was transformed into <italic>Photorhabdus laumondii</italic> TTO1 by electroporation (Fig. <xref rid="MOESM2" ref-type="media">S1</xref> B). However, we were not able to transform the original p46Cpf1-OP2 [<xref ref-type="bibr" rid="CR50">50</xref>] plasmid into <italic>Photorhabdus.</italic> Although it was previously described in [<xref ref-type="bibr" rid="CR52">52</xref>] that the pSC101 origin of replication replicates in <italic>Photorhabdus</italic>, we assume that the low copy [<xref ref-type="bibr" rid="CR53">53</xref>] number combined with the chloramphenicol resistance is not suitable for the cells. Therefore, we switched the origin of replication from pSC101 to p15A, which is distinguished by a higher number of copies per cell [<xref ref-type="bibr" rid="CR53">53</xref>], resulting in the successfully transformable pAR16 (Fig. <xref rid="MOESM2" ref-type="media">S1</xref>B).</p><p id="Par28">To determine the optimal starting OD<sub>600</sub> of the liquid CRISPR culture we selected OD&#x02009;=&#x02009;0.1, 0.2 and 0.5 after inoculation from an overnight culture. Since <italic>Photorhabdus</italic> has a much slower doubling time compared to <italic>E</italic>. <italic>coli</italic>, the required OD<sub>600</sub> of 0.8-1.0 could not be achieved within a single working day when starting OD<sub>600</sub> was below 0.5. Therefore, 0.5 was chosen as the starting OD<sub>600</sub> of the liquid culture for the following experiments. When the OD<sub>600</sub> of 0.8-1.0 was reached, the inducers for <italic>cpf1</italic> (Ara) and lambda red (ATC) were added. As the system was previously tested [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR50">50</xref>], we did not check the individual components of the system but only the overall method. To reduce cell growth and promote protein expression [<xref ref-type="bibr" rid="CR54">54</xref>&#x02013;<xref ref-type="bibr" rid="CR56">56</xref>], we set the temperature to 25&#x000a0;&#x000b0;C after induction and observed an editing efficiency of 100%, the efficiency decreases at higher temperatures (Fig. <xref rid="MOESM2" ref-type="media">S1</xref> C).</p></sec><sec id="Sec13"><title>Construction and optimizing of the single-plasmid approach</title><p id="Par29">Since we observed that <italic>Photorhabdus</italic> had poor transformation efficiency and <italic>Xenorhabdus</italic> was not transformable at all with the p46Cpf1-OP2 and its derivative pAR16, we decided to develop a single plasmid solution that had previously been described as particularly efficient in other strains [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. Based on our recently gained knowledge about the highly mobile pSEVA plasmid family we selected the broad-host vector pSEVA231 [<xref ref-type="bibr" rid="CR60">60</xref>]. We constructed a plasmid (pAR20) combining the components from the donor plasmid pAR18 and helper plasmid p46Cpf1-OP2. A major advantage of the method is the possibility to conjugate the plasmid directly from <italic>E</italic>. <italic>coli</italic> into the recipient strain without any integration of the plasmid or its parts into the genome.</p><p id="Par30">To test its efficiency, we again deleted <italic>stlA</italic> and found all colonies edited and showing the expected pigmentation phenotype. In addition to deleting smaller genes, we also wanted to evaluate the potential of the method for medium and large deletions and whether we could speed up the editing process. We focused on genes whose manipulation have visible phenotypes or result in metabolite changes easily detectable by mass spectrometry. The selected and successfully deleted genes/genome segments include <italic>stlA</italic> (1.9&#x000a0;kb deletion), <italic>gxpS</italic> (15.4&#x000a0;kb deletion) in TT01 and <italic>xcnA</italic> (7.5&#x000a0;kb deletion) and <italic>rdpABC</italic> (15.7&#x000a0;kb deletion) in <italic>Xenorhabdus nematophila</italic> involved in the biosynthesis of GameXPeptides [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR61">61</xref>], xenocoumacin [<xref ref-type="bibr" rid="CR62">62</xref>] and rhabdopeptides [<xref ref-type="bibr" rid="CR63">63</xref>], respectively (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Figure <xref rid="MOESM2" ref-type="media">S3</xref>).</p><p id="Par31">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Overview of successful gene/BGC editing</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Strain</th><th align="left">Locus tag</th><th align="left">Size (kb)</th><th align="left">Associated NP</th><th align="left">Efficiency (%)</th></tr><tr><th align="left"/><th align="left" colspan="5">Deletions</th></tr></thead><tbody><tr><td align="left">1</td><td align="left" rowspan="2"><p>
<italic>Photorhabdus</italic>
</p><p><italic>laumondii</italic> TTO1</p></td><td align="left">plu2234 (<italic>stlA</italic>)</td><td align="left">1.9</td><td align="left">Isopropylstilbene (<bold>1</bold>) [<xref ref-type="bibr" rid="CR64">64</xref>]</td><td align="left">100</td></tr><tr><td align="left">3</td><td align="left">plu3263 (<italic>gxpS</italic>)</td><td align="left">15.4</td><td align="left">GameXPeptides [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]</td><td align="left">100</td></tr><tr><td align="left">4</td><td align="left" rowspan="2"><p>
<italic>Xenorhabdus nematophila</italic>
</p><p>ATCC 19061</p></td><td align="left">XNC1_1711 (<italic>xcnA</italic>)</td><td align="left">7.5</td><td align="left">Xenocoumacins [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left">100</td></tr><tr><td align="left">5</td><td align="left">XNC1_2228&#x02013;2230 (<italic>rdpA</italic>-<italic>C</italic>)</td><td align="left">15.7</td><td align="left">Rhabdopeptides [<xref ref-type="bibr" rid="CR63">63</xref>]</td><td align="left">100</td></tr><tr><td align="left"/><td align="left" colspan="5">Promotor replacement/insertion</td></tr><tr><td align="left">1</td><td align="left" rowspan="4"><italic>P. laumondii</italic> TTO1</td><td align="left">&#x00394;P<sub>plu2186</sub>::P<sub>vanCC</sub></td><td align="left">&#x00394;0.2::1.3*</td><td align="left">Indigoidine (<bold>2</bold>) [<xref ref-type="bibr" rid="CR65">65</xref>]</td><td align="left">100</td></tr><tr><td align="left">2</td><td align="left">&#x00394;P<sub>plu2234</sub>::P<sub>vanCC</sub></td><td align="left">&#x00394;3.4::1.3*</td><td align="left">Isopropylstilbene (<bold>1</bold>) [<xref ref-type="bibr" rid="CR64">64</xref>]</td><td align="left">100</td></tr><tr><td align="left">3</td><td align="left">&#x00394;P<sub>plu3263</sub>::P<sub>vanCC</sub></td><td align="left">&#x00394;0.1::1.3*</td><td align="left">GameXPeptide A (<bold>3</bold>) [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]</td><td align="left">74</td></tr><tr><td align="left">4</td><td align="left">&#x00394;P<sub>plu1881</sub>::P<sub>vanCC</sub></td><td align="left">&#x00394;0.08::1.3*</td><td align="left">Glidobactins (<bold>4</bold>&#x02013;<bold>5</bold>) [<xref ref-type="bibr" rid="CR66">66</xref>]</td><td align="left">68</td></tr><tr><td align="left">5</td><td align="left" rowspan="2"><p>
<italic>X. nematophila</italic>
</p><p>ATCC 19061</p></td><td align="left">&#x00394;P<sub>XNC1_1711</sub>::P<sub>vanCC</sub></td><td align="left">&#x00394;0.3::1.3*</td><td align="left">Xenocoumacin I &#x00026; II (<bold>7</bold>&#x02013;<bold>8</bold>) [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left">100</td></tr><tr><td align="left">6</td><td align="left">&#x00394;P<sub>XNC1_2228</sub>::P<sub>vanCC</sub></td><td align="left">&#x00394;0.5::1.3*</td><td align="left">Rhabdopeptides (<bold>9</bold>&#x02013;<bold>12</bold>) [<xref ref-type="bibr" rid="CR63">63</xref>]</td><td align="left">100</td></tr></tbody></table><table-wrap-foot><p>* indicates the replaced sequence between homology arms by the 1.3&#x000a0;kb promoter sequence</p></table-wrap-foot></table-wrap>
</p><p id="Par33">Efficiency was determined by dividing the number of positive edited colonies by the total number of colonies tested, pictures of agarose gel electrophoresis are shown in Fig. <xref rid="MOESM2" ref-type="media">S5</xref>. Target sequences used for each approach are listed in Table <xref rid="MOESM2" ref-type="media">S2</xref>. Large gene deletions up to 15&#x000a0;kb in <italic>P. laumondii</italic> TTO1 and <italic>X</italic>. <italic>nematophila</italic> were easily obtained with high efficiency. Furthermore, we found no major impact on the metabolic profile after deletion of <italic>gxpS</italic> in <italic>P. laumondii</italic> TTO1 or <italic>xcnA</italic> in <italic>X</italic>. <italic>nematophila</italic> except the expected loss of GameXPeptides and xenocoumacins, respectively. Deletion of the <italic>rdpABC</italic> genes responsible for the production of rhabdopeptides (<bold>9</bold>&#x02013;<bold>12</bold>) in <italic>X</italic>. <italic>nematophila</italic> however also leads to an additional loss of xenortide A (<bold>6</bold>) as well as an increase of xenocoumacin II (<bold>8</bold>) (Fig. <xref rid="MOESM2" ref-type="media">S3</xref> B). Using the primer pair AR1634/1645, we also checked via colony PCR that the BGC for xenortide biosynthesis are still intact and present, excluding off-target effects associated with the CRISPR approach. It was already shown previously that xenortide biosynthesis is required for the production of leucine containing rhabdopeptides [<xref ref-type="bibr" rid="CR67">67</xref>] but for understanding the contribution of rhabdopeptide biosynthesis for xenortide biosynthesis additional experiments will be performed in the future.</p></sec><sec id="Sec14"><title>Metabolite profiling by insertion/replacement of regulatory sequences</title><p id="Par34">In addition to deletions, the use of small regulatory sequences like inducible promoters is particularly important in natural product research and for biosynthesis elucidation. For this purpose we modified and tested various inducible promoters described in [<xref ref-type="bibr" rid="CR48">48</xref>] featuring an insulator (<italic>riboJ</italic>) and a strong ribosomal binding site (RBS) to switch on and off different genes and gene clusters. As example, we selected <italic>indC</italic>, encoding a NRPS involved in the biosynthesis of the blue pigment indigoidine [<xref ref-type="bibr" rid="CR65">65</xref>]. This gene is silent under laboratory conditions but can be activated by the introduction of a foreign promoter [<xref ref-type="bibr" rid="CR65">65</xref>]. For our approach we &#x0201c;selected&#x0201d; 500&#x000a0;bp upstream of the <italic>indC</italic> coding sequence (HR-L) and 500&#x000a0;bp downstream of the start codon (HR-R), while the distance between both can be variable (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A). In contrast to a deletion, a promoter (P<sub>vanCC</sub>) sequence was assembled between the homology arms during Golden Gate Assembly (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A). After the editing approach, the sequence between the homology arms was replaced by the promoter sequence.</p><p id="Par35">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Single plasmid CRISPR/Cpf1 genome editing method for promoter exchange upstream of <italic>indC</italic>. <bold>A</bold>) Schematic representation of spacer sequence and homology regions selection; schematic cloning of synthetic dsDNA fragments harboring the repair templates and spacer sequence and the vanillic acid inducible promoter sequence (P<sub><italic>van</italic></sub>) into BsaI digested pAR20; schematic representation of the genome editing approach mediated by pAR20; the sequence between the homology arms is replaced by the promoter sequence; detailed genotype of pAR20 can be found in Table <xref rid="MOESM2" ref-type="media">S1</xref>. HR-L/R&#x02009;=&#x02009;homologues region L (left) or R (right), dsDNA&#x02009;=&#x02009;synthetic double strand DNA, DR&#x02009;=&#x02009;FnCpf1 specific direct repeat, red or green diamond&#x02009;=&#x02009;spacer sequence A or B, crossing dashed lines representing crossover event after CRISPR induced double strand break. <bold>B</bold>) Phenotypic comparison of induced and non-induced mutants; DMSO extract of induced mutant; biosynthesis of <bold>2.</bold> Figure was taken from BioRender.com and modified</p></caption><graphic xlink:href="12934_2024_2363_Fig1_HTML" id="d33e1403"/></fig>
</p><p id="Par36">We tested the colonies by PCR and achieved 100% editing (Fig. <xref rid="MOESM2" ref-type="media">S5</xref>). After induction of the promoter with vanillic acid, the typical blue pigment was observed (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B). We also applied this approach to other genes of known BGCs facilitating overexpression of previously moderate produced metabolites as well as production of previously &#x0201c;silent&#x0201d; BGCs. The successfully edited targets are listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> including six different compound families. MS spectra of induced and non-induced cultures after promoter insertion are shown in Figure <xref rid="MOESM2" ref-type="media">S4</xref>. In general, a significantly higher production of natural products was observed through compared to the wild type level. As previously observed during <italic>rdpABC</italic> deletion, the promoter exchange upstream of <italic>rdpA</italic> had an impact on xenortide A (<bold>6</bold>) production. While <bold>6</bold> was still detectable in the non-induced culture, it was significantly reduced after induction of the <italic>rdp</italic> BGC, which might be due to the cross talk between RdpABC and XrdAB as shown in Fig. <xref rid="MOESM2" ref-type="media">S3</xref>.</p></sec><sec id="Sec15"><title>Strain engineering, activation and refactoring of silent BGC</title><p id="Par37">In addition, complex BGC activations are also possible with our developed method. The activation of the putative safracin-associated BGC, named <italic>xsc</italic>, in <italic>Xenorhabdus sp</italic>. TS4 is such an example due to its bidirectional architecture (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A I). In initial experiments, the cluster was amplified in three parts and assembled on expression vectors, which were subsequently transformed into <italic>E</italic>. <italic>coli mtaA</italic> in various combinations (Fig. <xref rid="MOESM2" ref-type="media">S6</xref>). It was possible to produce different safracin derivatives with putative biosynthetic intermediates (Fig. <xref rid="MOESM2" ref-type="media">S6</xref> A-C). However, only small amounts of about 14&#x000a0;mg/L of SAC-B were produced (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C). For this reason, we decided to use our developed method for targeted cluster refactoring. For activation of the <italic>xsc</italic> cluster (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A I), the modified strong inducible <italic>vanR</italic>/P<sub>vanCC</sub> promoter was introduced upstream of <italic>xscA</italic> and a constitutive promoter (P<sub>proC</sub>) in the opposite direction upstream of <italic>xscI</italic> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A IIa). In addition, the 5&#x02019;-UTR between the RiboJ and the start codon was replaced with a translation enhancer sequence (g10T7 UTR (also abbreviated as T7g10), BBa_K1758100 (<ext-link ext-link-type="uri" xlink:href="http://parts.igem.org/Part:BBa_K1758100">http://parts.igem.org/Part:BBa_K1758100</ext-link>)). Besides the expected main products SAC-A and SAC-B, some putative biosynthetic precursors could be identified, which mainly indicated a weak procession by the SAM dependent N-methyltransferase XscI and FAD-dependent monooxygenase XscJ. To overcome this, we replaced P<sub>proC</sub> with a stronger constitutive promoter P<sub>proD</sub> in front of <italic>xscI</italic>, resulting in strain IIb (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A). Furthermore, to gain control over the prodrug/drug formation and to obtain exclusively SAC-B derivatives, we replaced the promoter upstream of <italic>xscK</italic> encoding the peptidase with a modified <italic>lacI</italic>/P<sub>tac</sub> IPTG inducible promoter while simultaneously deleting the putative resistance gene <italic>xscH</italic> [<xref ref-type="bibr" rid="CR68">68</xref>]. The resulting strain III showed an exclusive and increased production of SAC-B in the range of 208&#x02009;&#x000b1;&#x02009;3.5&#x000a0;mg/L. To achieve an even higher level of SAC-B production, we also tried to increase the availability of the modified tyrosine precursor 3-hydroxy-5-methyl-<italic>O</italic>-methyltyrosine (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B) [<xref ref-type="bibr" rid="CR69">69</xref>]. For this purpose, we introduced the biosynthetic genes <italic>xscD</italic>-<italic>G</italic> responsible for its formation on an L-arabinose inducible expression vector into strain III and used the empty vector as control. The introduction of the empty vector led to a drop in SAC-B production, which we assume was caused by stress from the added kanamycin. However, with the introduction of <italic>xscD</italic>-<italic>G</italic>, this effect could be compensated and a production titer of 336&#x02009;&#x000b1;&#x02009;26.6&#x000a0;mg/L could be achieved Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C). Base peak chromatograms of the described strains can be found in Figure <xref rid="MOESM2" ref-type="media">S8</xref> A.</p><p id="Par38">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Safracin cluster activation and refactoring in <italic>Xenorhabdus</italic> sp. TS4. <bold>A</bold>) Constructed safracin producer strains, I represents the wildtype strain, IIa promoter exchange strain with P<sub><italic>van</italic></sub>/P<sub><italic>proC</italic></sub> insertion, IIb P<sub><italic>van</italic></sub>/P<sub><italic>proD</italic></sub> insertion and strain II with additional P<sub>tac</sub> insertion upstream of <italic>xscK</italic> with <italic>xscH</italic> deletion. <bold>B</bold>) Putative biosynthesis of safracins; tailoring enzyme modifications are highlighted; Tyr* indicates the specificity of the XscC A domain for 3-hydroxy-5-methyl-o-methyltyrosine; &#x0201c;Unnatural&#x0201d; further modification of SAC-B by SfmCy resulting in <bold>24</bold>. <bold>C</bold>) Comparison of SAC-A and SAC-B production between the constructed strains. A: adenylation domain, C: condensation domain, R: reduction domain, PCP: peptidylcarrier protein (small black circle)</p></caption><graphic xlink:href="12934_2024_2363_Fig2_HTML" id="d33e1598"/></fig>
</p><p id="Par39">In addition to increasing the concentration of SAC-B, we also tested whether the product could be further functionalized. It was previously shown [<xref ref-type="bibr" rid="CR36">36</xref>] that other &#x0201c;unnatural&#x0201d; safracin derivatives could be generated by adding modified precursors such as 3-hydroxy-5-methyl-O-ethyltyrosine. It was also shown previously [<xref ref-type="bibr" rid="CR70">70</xref>] that functionalization of SAC-B by enzymes from the saframycin biosynthetic pathway of <italic>S</italic>. <italic>lavendulae</italic> was possible. We therefore introduced the codon-optimized <italic>sfmCy2</italic> gene, encoding a secreted FAD-dependent oxidoreductase, by integration into the genome (Figure <xref rid="MOESM2" ref-type="media">S7</xref> B). SfmCy2 is responsible for the periplasmic oxidative deamination of the N-terminus [<xref ref-type="bibr" rid="CR71">71</xref>]. After induction of all components in the production strain, we were able to detect a new mass of <italic>m/z</italic>&#x02009;=&#x02009;522.223 [M&#x02009;+&#x02009;H-H<sub>2</sub>O]<sup>+</sup> (<bold>24</bold>; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B, <xref rid="MOESM2" ref-type="media">S8</xref> B). We hypothesize that this is the oxidatively deaminated derivative of SAC-B (<bold>24</bold>, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B), which is supported by the MS-MS fragmentation pattern (Fig. <xref rid="MOESM2" ref-type="media">S7</xref> C). However, further studies are required to confirm its structure.</p></sec></sec><sec id="Sec16" sec-type="conclusion"><title>Conclusions</title><p id="Par40">In this work, we describe a simple and easy-to-use method for markerless genome editing in <italic>Photorhabdus</italic> and <italic>Xenorhabdus</italic>. To the best of our knowledge, this is the first description of CRISPR technology in the genus <italic>Xenorhabdus</italic>. The reduction to a single plasmid makes it much easier to work with non-laboratory organisms, which often show reduced growth with two resistance markers. The insertion of synthetic dsDNA fragments carrying both the repair template and the CRISPR target sequence makes vector assembly relatively simple. Furthermore, the easy transferability of the pSEVA vectors by conjugation, enabled by oriT, opens up the potential application to many different bacteria. In contrast to previously described genome editing methods, the process described here is straightforward and does not require the stepwise integration of one or more plasmids into the genome [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. From the transfer of the vector to the desired and resistance-free production strain, only four steps are required, which can be performed in six days (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). On day seven, a new round of editing can be started, allowing rapid sequential editing. In &#x0201c;classical&#x0201d; BGC activation, R6K ori-based plasmids or a resistance cassette are often introduced in front of the desired gene, which has the disadvantage that iterative rounds of activation are not possible [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Due to the presence of the <italic>sacB</italic> gene on our vector and the fact that it is freely replicable, it can be easily cured by the addition of sucrose. Furthermore, our method is efficient for small and large deletions, as well as for smaller insertions, such as the insertion of inducible promoter sequences, without producing chimeric colonies (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). We hypothesize that this is due to the use of two CRISPR sites per target. Targeting both ends of the sequence to be edited increases efficiency, as has been shown for <italic>Streptomyces</italic> [<xref ref-type="bibr" rid="CR73">73</xref>]. Based on our technology, production titers of the high-value compound safracin B could be increased far beyond titers previously described [<xref ref-type="bibr" rid="CR36">36</xref>]. Genomic integration of modifying enzymes also increased product variability and yielded a new, previously undescribed derivative <bold>24</bold>. The application of the single plasmid system and pSEVA based expression plasmids should therefore facilitate a variety of future studies in <italic>Photorhabdus</italic>, <italic>Xenorhabdus</italic>, as well as other bacteria, including regulatory network analysis, activation of silent natural product gene clusters, introduction of novel metabolic pathways, and design of optimized chassis strains for heterologous production of desired natural products.</p><p id="Par41">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Overview of the developed single plasmid CRISPR-Cpf1 genome editing workflow. The approach starts with conjugation of the target specific pAR20 into the strain to be edited (day 0); selection of conjugates and induction of CRISPR/Cpf1 components (day 3); plasmid curing of correct edited strains with sucrose (day 5); screening for new or known compounds (day 6); entering a new editing cycle (day 7). (Km&#x02009;=&#x02009;kanamycin; L-Ara&#x02009;=&#x02009;L-Arabinose; ATC&#x02009;=&#x02009;anhydrotetracycline). Figure created with BioRender.com</p></caption><graphic xlink:href="12934_2024_2363_Fig3_HTML" id="d33e1712"/></fig>
</p></sec><sec sec-type="supplementary-material"><sec id="Sec17"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12934_2024_2363_MOESM1_ESM.xlsx"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p><p>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12934_2024_2363_MOESM2_ESM.docx"><caption><p>Supplementary Material 2</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful to Peter Gr&#x000fc;n for help with the HPLC/MS analysis and maintenance of the analytical and preparative HPLC/MS systems. Furthermore, we thank Stefanie Lamberth for laboratory maintenance and preparation of large-scale cultures.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Alexander Rill: method development, genetic construction, strain engineering data preparation and visualization, paper writing, Lei Zhao: vector construction for heterologous expression of xsc BGC in E. coli, isolation and structure elucidation of compound 20, Helge B. Bode: supervision, paper writing.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the BMBF project RhabdoFerm and in part by the ERC advanced grant SYNPEP (835108).</p><p>Open Access funding enabled and organized by Projekt DEAL.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in this article and its supplementary information files.</p></notes><notes><title>Declarations</title><notes id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par63">Not applicable.</p></notes><notes id="FPar4"><title>Consent for publication</title><p id="Par64">Not applicable.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par45">This work was filed as part of a patent by the Max-Planck Society with A.R. and H.B.B. as main inventors.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorholt</surname><given-names>JA</given-names></name></person-group><article-title>Microbial life in the phyllosphere</article-title><source>Nat Rev Microbiol</source><year>2012</year><volume>10</volume><issue>12</issue><fpage>828</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2910</pub-id><?supplied-pmid 23154261?><pub-id pub-id-type="pmid">23154261</pub-id>
</element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molloy</surname><given-names>EM</given-names></name><name><surname>Hertweck</surname><given-names>C</given-names></name></person-group><article-title>Antimicrobial discovery inspired by ecological interactions</article-title><source>Curr Opin Microbiol</source><year>2017</year><volume>39</volume><fpage>121</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2017.09.006</pub-id><?supplied-pmid 29169087?><pub-id pub-id-type="pmid">29169087</pub-id>
</element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Singh S, et al. Role of secondary metabolites in establishment of the mutualistic partnership between Xenorhabdus nematophila and the entomopathogenic nematode Steinernema carpocapsae. Appl Environ Microbiol. 2015;81(2):754&#x02013;64.</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challinor</surname><given-names>VL</given-names></name><name><surname>Bode</surname><given-names>HB</given-names></name></person-group><article-title>Bioactive natural products from novel microbial sources</article-title><source>Ann N Y Acad Sci</source><year>2015</year><volume>1354</volume><fpage>82</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1111/nyas.12954</pub-id><?supplied-pmid 26509922?><pub-id pub-id-type="pmid">26509922</pub-id>
</element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzola</surname><given-names>M</given-names></name><etal/></person-group><article-title>Protozoan-induced regulation of cyclic lipopeptide biosynthesis is an effective predation defense mechanism for Pseudomonas fluorescens</article-title><source>Appl Environ Microbiol</source><year>2009</year><volume>75</volume><issue>21</issue><fpage>6804</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1128/AEM.01272-09</pub-id><?supplied-pmid 19717630?><pub-id pub-id-type="pmid">19717630</pub-id>
</element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Bodman</surname><given-names>SB</given-names></name><name><surname>Willey</surname><given-names>JM</given-names></name><name><surname>Diggle</surname><given-names>SP</given-names></name></person-group><article-title>Cell-cell communication in bacteria: united we stand</article-title><source>J Bacteriol</source><year>2008</year><volume>190</volume><issue>13</issue><fpage>4377</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1128/JB.00486-08</pub-id><pub-id pub-id-type="pmid">18456806</pub-id>
</element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>AM</given-names></name><name><surname>Schuster</surname><given-names>M</given-names></name><name><surname>Rumbaugh</surname><given-names>KP</given-names></name></person-group><article-title>Working together for the common good: cell-cell communication in bacteria</article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><issue>9</issue><fpage>2131</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1128/JB.00143-12</pub-id><?supplied-pmid 22389476?><pub-id pub-id-type="pmid">22389476</pub-id>
</element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group><article-title>Natural products as sources of new drugs from 1981 to 2014</article-title><source>J Nat Prod</source><year>2016</year><volume>79</volume><issue>3</issue><fpage>629</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><?supplied-pmid 26852623?><pub-id pub-id-type="pmid">26852623</pub-id>
</element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacFadden</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Antibiotic resistance increases with local temperature</article-title><source>Nat Clim Chang</source><year>2018</year><volume>8</volume><issue>6</issue><fpage>510</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/s41558-018-0161-6</pub-id><?supplied-pmid 30369964?><pub-id pub-id-type="pmid">30369964</pub-id>
</element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Climate change microbiology - problems and perspectives</article-title><source>Nat Rev Microbiol</source><year>2019</year><volume>17</volume><issue>6</issue><fpage>391</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/s41579-019-0178-5</pub-id><?supplied-pmid 31092905?><pub-id pub-id-type="pmid">31092905</pub-id>
</element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadjithomas</surname><given-names>M</given-names></name><etal/></person-group><article-title>IMG-ABC: new features for bacterial secondary metabolism analysis and targeted biosynthetic gene cluster discovery in thousands of microbial genomes</article-title><source>Nucleic Acids Res</source><year>2017</year><volume>45</volume><issue>D1</issue><fpage>D560</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1103</pub-id><?supplied-pmid 27903896?><pub-id pub-id-type="pmid">27903896</pub-id>
</element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K</given-names></name><etal/></person-group><article-title>antiSMASH 6.0: improving cluster detection and comparison capabilities</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><issue>W1</issue><fpage>W29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id><?supplied-pmid 33978755?><pub-id pub-id-type="pmid">33978755</pub-id>
</element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kautsar</surname><given-names>SA</given-names></name><etal/></person-group><article-title>MIBiG 2.0: a repository for biosynthetic gene clusters of known function</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><issue>D1</issue><fpage>D454</fpage><lpage>8</lpage><?supplied-pmid 31612915?><pub-id pub-id-type="pmid">31612915</pub-id>
</element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutledge</surname><given-names>PJ</given-names></name><name><surname>Challis</surname><given-names>GL</given-names></name></person-group><article-title>Discovery of microbial natural products by activation of silent biosynthetic gene clusters</article-title><source>Nat Rev Microbiol</source><year>2015</year><volume>13</volume><issue>8</issue><fpage>509</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3496</pub-id><?supplied-pmid 26119570?><pub-id pub-id-type="pmid">26119570</pub-id>
</element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Engineering of Streptomyces lividans for heterologous expression of secondary metabolite gene clusters</article-title><source>Microb Cell Fact</source><year>2020</year><volume>19</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s12934-020-1277-8</pub-id><?supplied-pmid 31918711?><pub-id pub-id-type="pmid">31918711</pub-id>
</element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group><article-title>ExoCET: exonuclease in vitro assembly combined with RecET recombination for highly efficient direct DNA cloning from complex genomes</article-title><source>Nucleic Acids Res</source><year>2018</year><volume>46</volume><issue>5</issue><fpage>e28</fpage><pub-id pub-id-type="doi">10.1093/nar/gkx1249</pub-id><?supplied-pmid 29240926?><pub-id pub-id-type="pmid">29240926</pub-id>
</element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>J</given-names></name><etal/></person-group><article-title>A new recombineering system for Photorhabdus and Xenorhabdus</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><issue>6</issue><fpage>e36</fpage><pub-id pub-id-type="doi">10.1093/nar/gku1336</pub-id><?supplied-pmid 25539914?><pub-id pub-id-type="pmid">25539914</pub-id>
</element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Direct cloning and heterologous expression of natural product biosynthetic gene clusters by transformation-associated recombination</article-title><source>Methods Enzymol</source><year>2019</year><volume>621</volume><fpage>87</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/bs.mie.2019.02.026</pub-id><?supplied-pmid 31128791?><pub-id pub-id-type="pmid">31128791</pub-id>
</element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting</article-title><source>Nat Biotechnol</source><year>2012</year><volume>30</volume><issue>5</issue><fpage>440</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nbt.2183</pub-id><?supplied-pmid 22544021?><pub-id pub-id-type="pmid">22544021</pub-id>
</element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myronovskyi</surname><given-names>M</given-names></name><name><surname>Luzhetskyy</surname><given-names>A</given-names></name></person-group><article-title>Native and engineered promoters in natural product discovery</article-title><source>Nat Prod Rep</source><year>2016</year><volume>33</volume><issue>8</issue><fpage>1006</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1039/C6NP00002A</pub-id><?supplied-pmid 27438486?><pub-id pub-id-type="pmid">27438486</pub-id>
</element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Activation of silent biosynthetic gene clusters using transcription factor decoys</article-title><source>Nat Chem Biol</source><year>2019</year><volume>15</volume><issue>2</issue><fpage>111</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/s41589-018-0187-0</pub-id><?supplied-pmid 30598544?><pub-id pub-id-type="pmid">30598544</pub-id>
</element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><etal/></person-group><article-title>Development and application of an efficient recombineering system for Burkholderia glumae and Burkholderia plantarii</article-title><source>Microb Biotechnol</source><year>2021</year><volume>14</volume><issue>4</issue><fpage>1809</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13840</pub-id><?supplied-pmid 34191386?><pub-id pub-id-type="pmid">34191386</pub-id>
</element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Single-stranded DNA-Binding protein and exogenous RecBCD inhibitors enhance phage-derived homologous recombination in Pseudomonas</article-title><source>iScience</source><year>2019</year><volume>14</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.isci.2019.03.007</pub-id><?supplied-pmid 30921732?><pub-id pub-id-type="pmid">30921732</pub-id>
</element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y</given-names></name><etal/></person-group><article-title>CRISPR-Cas9 Based Engineering of Actinomycetal genomes</article-title><source>ACS Synth Biol</source><year>2015</year><volume>4</volume><issue>9</issue><fpage>1020</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.5b00038</pub-id><?supplied-pmid 25806970?><pub-id pub-id-type="pmid">25806970</pub-id>
</element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>HB</given-names></name></person-group><article-title>Entomopathogenic bacteria as a source of secondary metabolites</article-title><source>Curr Opin Chem Biol</source><year>2009</year><volume>13</volume><issue>2</issue><fpage>224</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2009.02.037</pub-id><?supplied-pmid 19345136?><pub-id pub-id-type="pmid">19345136</pub-id>
</element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>YM</given-names></name><name><surname>Bode</surname><given-names>HB</given-names></name></person-group><article-title>Chemical language and warfare of bacterial natural products in bacteria-nematode-insect interactions</article-title><source>Nat Prod Rep</source><year>2018</year><volume>35</volume><issue>4</issue><fpage>309</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1039/C7NP00054E</pub-id><?supplied-pmid 29359226?><pub-id pub-id-type="pmid">29359226</pub-id>
</element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hapeshi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Iso-propyl stilbene: a life cycle signal?</article-title><source>Microbiol (Reading)</source><year>2019</year><volume>165</volume><issue>5</issue><fpage>516</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000790</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brameyer</surname><given-names>S</given-names></name><name><surname>Heermann</surname><given-names>R</given-names></name></person-group><article-title>Quorum sensing and LuxR solos in Photorhabdus</article-title><source>Curr Top Microbiol Immunol</source><year>2017</year><volume>402</volume><fpage>103</fpage><lpage>19</lpage><?supplied-pmid 27848037?><pub-id pub-id-type="pmid">27848037</pub-id>
</element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodou</surname><given-names>A</given-names></name><name><surname>Ankrah</surname><given-names>DO</given-names></name><name><surname>Stathopoulos</surname><given-names>C</given-names></name></person-group><article-title>Toxins and secretion systems of Photorhabdus luminescens</article-title><source>Toxins (Basel)</source><year>2010</year><volume>2</volume><issue>6</issue><fpage>1250</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.3390/toxins2061250</pub-id><?supplied-pmid 22069636?><pub-id pub-id-type="pmid">22069636</pub-id>
</element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Antifungal activity of different Xenorhabdus and Photorhabdus species against various fungal phytopathogens and identification of the antifungal compounds from X. Szentirmaii</article-title><source>Appl Microbiol Biotechnol</source><year>2021</year><volume>105</volume><issue>13</issue><fpage>5517</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1007/s00253-021-11435-3</pub-id><?supplied-pmid 34250572?><pub-id pub-id-type="pmid">34250572</pub-id>
</element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>JM</given-names></name><name><surname>Kontnik</surname><given-names>R</given-names></name><name><surname>Clardy</surname><given-names>J</given-names></name></person-group><article-title>Regulating alternative lifestyles in entomopathogenic bacteria</article-title><source>Curr Biol</source><year>2010</year><volume>20</volume><issue>1</issue><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2009.10.059</pub-id><?supplied-pmid 20022247?><pub-id pub-id-type="pmid">20022247</pub-id>
</element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>E</given-names></name><etal/></person-group><article-title>Promoter activation in delta hfq mutants as an efficient Tool for Specialized Metabolite Production enabling direct Bioactivity Testing</article-title><source>Angew Chem Int Ed Engl</source><year>2019</year><volume>58</volume><issue>52</issue><fpage>18957</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1002/anie.201910563</pub-id><?supplied-pmid 31693786?><pub-id pub-id-type="pmid">31693786</pub-id>
</element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Bacterial genome editing by coupling cre-lox and CRISPR-Cas9 systems</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><issue>11</issue><fpage>e0241867</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0241867</pub-id><?supplied-pmid 33147260?><pub-id pub-id-type="pmid">33147260</pub-id>
</element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><etal/></person-group><article-title>CRAGE enables rapid activation of biosynthetic gene clusters in undomesticated bacteria</article-title><source>Nat Microbiol</source><year>2019</year><volume>4</volume><issue>12</issue><fpage>2498</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0573-8</pub-id><?supplied-pmid 31611640?><pub-id pub-id-type="pmid">31611640</pub-id>
</element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zetsche</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system</article-title><source>Cell</source><year>2015</year><volume>163</volume><issue>3</issue><fpage>759</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.09.038</pub-id><?supplied-pmid 26422227?><pub-id pub-id-type="pmid">26422227</pub-id>
</element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasco</surname><given-names>A</given-names></name><etal/></person-group><article-title>Molecular characterization of the safracin biosynthetic pathway from Pseudomonas fluorescens A2-2: designing new cytotoxic compounds</article-title><source>Mol Microbiol</source><year>2005</year><volume>56</volume><issue>1</issue><fpage>144</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04433.x</pub-id><?supplied-pmid 15773985?><pub-id pub-id-type="pmid">15773985</pub-id>
</element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YY</given-names></name><etal/></person-group><article-title>A cryptic palmitoyl chain involved in Safracin Biosynthesis facilitates Post-NRPS modifications</article-title><source>Org Lett</source><year>2022</year><volume>24</volume><issue>1</issue><fpage>127</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.1c03741</pub-id><?supplied-pmid 34882414?><pub-id pub-id-type="pmid">34882414</pub-id>
</element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>JD</given-names></name><name><surname>Williams</surname><given-names>RM</given-names></name></person-group><article-title>Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics</article-title><source>Chem Rev</source><year>2002</year><volume>102</volume><issue>5</issue><fpage>1669</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1021/cr010212u</pub-id><?supplied-pmid 11996547?><pub-id pub-id-type="pmid">11996547</pub-id>
</element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinehart</surname><given-names>KL</given-names></name></person-group><article-title>Antitumor compounds from tunicates</article-title><source>Med Res Rev</source><year>2000</year><volume>20</volume><issue>1</issue><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1098-1128(200001)20:1&#x0003c;1::AID-MED1&#x0003e;3.0.CO;2-A</pub-id><?supplied-pmid 10608919?><pub-id pub-id-type="pmid">10608919</pub-id>
</element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schofield</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743</article-title><source>Environ Microbiol</source><year>2015</year><volume>17</volume><issue>10</issue><fpage>3964</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.12908</pub-id><?supplied-pmid 26013440?><pub-id pub-id-type="pmid">26013440</pub-id>
</element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name></person-group><article-title>A scalable total synthesis of the Antitumor agents Et-743 and Lurbinectedin</article-title><source>Angew Chem Int Ed Engl</source><year>2019</year><volume>58</volume><issue>12</issue><fpage>3972</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1002/anie.201900035</pub-id><?supplied-pmid 30689274?><pub-id pub-id-type="pmid">30689274</pub-id>
</element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>VH</given-names></name><etal/></person-group><article-title>Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics</article-title><source>Nat Prod Rep</source><year>2015</year><volume>32</volume><issue>2</issue><fpage>328</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1039/C4NP00051J</pub-id><?supplied-pmid 25273374?><pub-id pub-id-type="pmid">25273374</pub-id>
</element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><etal/></person-group><article-title>A concise and practical semisynthesis of Ecteinascidin 743 and (-)-Jorumycin</article-title><source>Eur J Org Chem</source><year>2017</year><volume>2017</volume><issue>5</issue><fpage>975</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201601409</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>E</given-names></name><etal/></person-group><article-title>Biosynthesis and function of simple amides in Xenorhabdus doucetiae</article-title><source>Environ Microbiol</source><year>2017</year><volume>19</volume><issue>11</issue><fpage>4564</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.13919</pub-id><?supplied-pmid 28892274?><pub-id pub-id-type="pmid">28892274</pub-id>
</element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>E</given-names></name><etal/></person-group><article-title>easyPACId, a simple method for Induced Production, isolation, identification, and testing of Natural products from Proteobacteria</article-title><source>Bio-protocol</source><year>2023</year><volume>13</volume><issue>13</issue><fpage>e4709</fpage><pub-id pub-id-type="doi">10.21769/BioProtoc.4709</pub-id><?supplied-pmid 37449040?><pub-id pub-id-type="pmid">37449040</pub-id>
</element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>HB</given-names></name><etal/></person-group><article-title>Determination of the absolute configuration of peptide natural products by using stable isotope labeling and mass spectrometry</article-title><source>Chemistry</source><year>2012</year><volume>18</volume><issue>8</issue><fpage>2342</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/chem.201103479</pub-id><?supplied-pmid 22266804?><pub-id pub-id-type="pmid">22266804</pub-id>
</element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobias</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus</article-title><source>Nat Microbiol</source><year>2017</year><volume>2</volume><issue>12</issue><fpage>1676</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/s41564-017-0039-9</pub-id><?supplied-pmid 28993611?><pub-id pub-id-type="pmid">28993611</pub-id>
</element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Escherichia coli Marionette strains with 12 highly optimized small-molecule sensors</article-title><source>Nat Chem Biol</source><year>2019</year><volume>15</volume><issue>2</issue><fpage>196</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1038/s41589-018-0168-3</pub-id><?supplied-pmid 30478458?><pub-id pub-id-type="pmid">30478458</pub-id>
</element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaner</surname><given-names>NC</given-names></name><etal/></person-group><article-title>A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum</article-title><source>Nat Methods</source><year>2013</year><volume>10</volume><issue>5</issue><fpage>407</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2413</pub-id><?supplied-pmid 23524392?><pub-id pub-id-type="pmid">23524392</pub-id>
</element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ao</surname><given-names>X</given-names></name><etal/></person-group><article-title>A multiplex genome editing method for Escherichia coli based on CRISPR-Cas12a</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>2307</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02307</pub-id><?supplied-pmid 30356638?><pub-id pub-id-type="pmid">30356638</pub-id>
</element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brachmann</surname><given-names>AO</given-names></name><etal/></person-group><article-title>A type II polyketide synthase is responsible for anthraquinone biosynthesis in Photorhabdus luminescens</article-title><source>ChemBioChem</source><year>2007</year><volume>8</volume><issue>14</issue><fpage>1721</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/cbic.200700300</pub-id><?supplied-pmid 17722122?><pub-id pub-id-type="pmid">17722122</pub-id>
</element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>J</given-names></name><etal/></person-group><article-title>A practical guide to recombineering in Photorhabdus and Xenorhabdus</article-title><source>Curr Top Microbiol Immunol</source><year>2017</year><volume>402</volume><fpage>195</fpage><lpage>213</lpage><?supplied-pmid 28154939?><pub-id pub-id-type="pmid">28154939</pub-id>
</element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>R</given-names></name><name><surname>Bujard</surname><given-names>H</given-names></name></person-group><article-title>Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><issue>6</issue><fpage>1203</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1093/nar/25.6.1203</pub-id><?supplied-pmid 9092630?><pub-id pub-id-type="pmid">9092630</pub-id>
</element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirano</surname><given-names>Y</given-names></name><name><surname>Shibata</surname><given-names>D</given-names></name></person-group><article-title>Low temperature cultivation of Escherichia coli carrying a rice lipoxygenase L-2 cDNA produces a soluble and active enzyme at a high level</article-title><source>FEBS Lett</source><year>1990</year><volume>271</volume><issue>1&#x02013;2</issue><fpage>128</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(90)80388-Y</pub-id><?supplied-pmid 2121525?><pub-id pub-id-type="pmid">2121525</pub-id>
</element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataeva</surname><given-names>I</given-names></name><etal/></person-group><article-title>Improving solubility of Shewanella oneidensis MR-1 and Clostridium thermocellum JW-20 proteins expressed into Esherichia Coli</article-title><source>J Proteome Res</source><year>2005</year><volume>4</volume><issue>6</issue><fpage>1942</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1021/pr050108j</pub-id><?supplied-pmid 16335938?><pub-id pub-id-type="pmid">16335938</pub-id>
</element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volonte</surname><given-names>F</given-names></name><etal/></person-group><article-title>Optimization of glutaryl-7-aminocephalosporanic acid acylase expression in E. Coli</article-title><source>Protein Expr Purif</source><year>2008</year><volume>61</volume><issue>2</issue><fpage>131</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.pep.2008.05.010</pub-id><?supplied-pmid 18586517?><pub-id pub-id-type="pmid">18586517</pub-id>
</element-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Baldanta S, Guevara G, Navarro-Llorens JM. <italic>SEVA-Cpf1, a CRISPR-Cas12a vector for genome editing in cyanobacteria</italic> Microb Cell Fact, 2022. 21(1): p. 103.</mixed-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>W</given-names></name><etal/></person-group><article-title>Design and construction of portable CRISPR-Cpf1-Mediated genome editing in Bacillus subtilis 168 oriented toward multiple utilities</article-title><source>Front Bioeng Biotechnol</source><year>2020</year><volume>8</volume><fpage>524676</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2020.524676</pub-id><?supplied-pmid 32984297?><pub-id pub-id-type="pmid">32984297</pub-id>
</element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>15179</fpage><pub-id pub-id-type="doi">10.1038/ncomms15179</pub-id><?supplied-pmid 28469274?><pub-id pub-id-type="pmid">28469274</pub-id>
</element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva-Rocha</surname><given-names>R</given-names></name><etal/></person-group><article-title>The standard European Vector Architecture (SEVA): a coherent platform for the analysis and deployment of complex prokaryotic phenotypes</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><issue>Database issue</issue><fpage>D666</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1119</pub-id><?supplied-pmid 23180763?><pub-id pub-id-type="pmid">23180763</pub-id>
</element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nollmann</surname><given-names>FI</given-names></name><etal/></person-group><article-title>Insect-specific production of new GameXPeptides in Photorhabdus luminescens TTO1, widespread natural products in entomopathogenic bacteria</article-title><source>ChemBioChem</source><year>2015</year><volume>16</volume><issue>2</issue><fpage>205</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/cbic.201402603</pub-id><?supplied-pmid 25425189?><pub-id pub-id-type="pmid">25425189</pub-id>
</element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>D</given-names></name><etal/></person-group><article-title>Genetic analysis of xenocoumacin antibiotic production in the mutualistic bacterium Xenorhabdus nematophila</article-title><source>Mol Microbiol</source><year>2009</year><volume>73</volume><issue>5</issue><fpage>938</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06817.x</pub-id><?supplied-pmid 19682255?><pub-id pub-id-type="pmid">19682255</pub-id>
</element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimer</surname><given-names>D</given-names></name><etal/></person-group><article-title>Rhabdopeptides as insect-specific virulence factors from entomopathogenic bacteria</article-title><source>ChemBioChem</source><year>2013</year><volume>14</volume><issue>15</issue><fpage>1991</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/cbic.201300205</pub-id><?supplied-pmid 24038745?><pub-id pub-id-type="pmid">24038745</pub-id>
</element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Bacterial biosynthesis of a multipotent stilbene</article-title><source>Angew Chem Int Ed Engl</source><year>2008</year><volume>47</volume><issue>10</issue><fpage>1942</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1002/anie.200705148</pub-id><?supplied-pmid 18236486?><pub-id pub-id-type="pmid">18236486</pub-id>
</element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brachmann</surname><given-names>AO</given-names></name><etal/></person-group><article-title>Triggering the production of the cryptic blue pigment indigoidine from Photorhabdus luminescens</article-title><source>J Biotechnol</source><year>2012</year><volume>157</volume><issue>1</issue><fpage>96</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.10.002</pub-id><?supplied-pmid 22085970?><pub-id pub-id-type="pmid">22085970</pub-id>
</element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Activation, structure, biosynthesis and bioactivity of glidobactin-like Proteasome inhibitors from Photorhabdus Laumondii</article-title><source>ChemBioChem</source><year>2021</year><volume>22</volume><issue>9</issue><fpage>1582</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/cbic.202100014</pub-id><?supplied-pmid 33452852?><pub-id pub-id-type="pmid">33452852</pub-id>
</element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X</given-names></name><etal/></person-group><article-title>Entomopathogenic bacteria use multiple mechanisms for bioactive peptide library design</article-title><source>Nat Chem</source><year>2017</year><volume>9</volume><issue>4</issue><fpage>379</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/nchem.2671</pub-id><?supplied-pmid 28338679?><pub-id pub-id-type="pmid">28338679</pub-id>
</element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>N</given-names></name><etal/></person-group><article-title>Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis</article-title><source>Acta Pharm Sin B</source><year>2023</year><volume>13</volume><issue>3</issue><fpage>1318</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2022.10.005</pub-id><?supplied-pmid 36970210?><pub-id pub-id-type="pmid">36970210</pub-id>
</element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Biosynthesis of 3-hydroxy-5-methyl-o-methyltyrosine in the saframycin/ safracin biosynthetic pathway</article-title><source>J Microbiol Biotechnol</source><year>2009</year><volume>19</volume><issue>5</issue><fpage>439</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.4014/jmb.0808.484</pub-id><?supplied-pmid 19494690?><pub-id pub-id-type="pmid">19494690</pub-id>
</element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Characterization of the saframycin A gene cluster from Streptomyces lavendulae NRRL 11002 revealing a nonribosomal peptide synthetase system for assembling the unusual tetrapeptidyl skeleton in an iterative manner</article-title><source>J Bacteriol</source><year>2008</year><volume>190</volume><issue>1</issue><fpage>251</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1128/JB.00826-07</pub-id><?supplied-pmid 17981978?><pub-id pub-id-type="pmid">17981978</pub-id>
</element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>LQ</given-names></name><etal/></person-group><article-title>Catalysis of Extracellular Deamination by a FAD-Linked oxidoreductase after Prodrug Maturation in the biosynthesis of Saframycin A</article-title><source>Angew Chem Int Ed Engl</source><year>2017</year><volume>56</volume><issue>31</issue><fpage>9116</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/anie.201704726</pub-id><?supplied-pmid 28561936?><pub-id pub-id-type="pmid">28561936</pub-id>
</element-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Ke J et al. CRAGE-CRISPR facilitates rapid activation of secondary metabolite biosynthetic gene clusters in bacteria. Cell Chem Biol, 2021.</mixed-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>RE</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name></person-group><article-title>High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system</article-title><source>ACS Synth Biol</source><year>2015</year><volume>4</volume><issue>6</issue><fpage>723</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1021/sb500351f</pub-id><?supplied-pmid 25458909?><pub-id pub-id-type="pmid">25458909</pub-id>
</element-citation></ref></ref-list></back></article>